Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.
As of Mar. 2026, Asian Phytoceuticals PCL has a Sloan Ratio of -10.39%, indicating there is a warning stage of accrual build up.
Asian Phytoceuticals PCL (BKK:APCO-R) Sloan Ratio % Explanation
A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.
If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.
If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.
If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.
As of Mar. 2026, Asian Phytoceuticals PCL has a Sloan Ratio of -10.39%, indicating there is a warning stage of accrual build up.
Asian Phytoceuticals PCL Sloan Ratio % Related Terms
Asian Phytoceuticals PCL Sloan Ratio % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:APCO-R vs PG, CL, KVUE: Sloan Ratio % Comparison
For the Household & Personal Products subindustry, Asian Phytoceuticals PCL's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asian Phytoceuticals PCL Sloan Ratio % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Asian Phytoceuticals PCL's Sloan Ratio % distribution charts can be found below:
* The bar in red indicates where Asian Phytoceuticals PCL's Sloan Ratio % falls into.
Asian Phytoceuticals PCL Sloan Ratio % Calculation
Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.
Asian Phytoceuticals PCL's Sloan Ratio for the fiscal year that ended in Dec. 2025 is calculated as
Asian Phytoceuticals PCL's Net Income for the trailing twelve months (TTM) ended in Mar. 2026 was 13.234 (Jun. 2025 ) + 14.787 (Sep. 2025 ) + 14.883 (Dec. 2025 ) + 17.559 (Mar. 2026 ) = ฿60.5 Mil.
Asian Phytoceuticals PCL's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was 0.894 (Jun. 2025 ) + 16.196 (Sep. 2025 ) + 21.852 (Dec. 2025 ) + 17.069 (Mar. 2026 ) = ฿56.0 Mil.
Asian Phytoceuticals PCL's Cash Flow from Investing for the trailing twelve months (TTM) ended in Mar. 2026 was 57.135 (Jun. 2025 ) + 1.094 (Sep. 2025 ) + 0.97 (Dec. 2025 ) + 12.651 (Mar. 2026 ) = ฿71.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asian Phytoceuticals PCL (BKK:APCO-R) has a Sloan Ratio % of -10.39% as of Mar. 2026. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Asian Phytoceuticals PCL and its competitors.
Is Asian Phytoceuticals PCL's Sloan Ratio % too high?
Asian Phytoceuticals PCL's current Sloan Ratio % is -10.39%. Overall, Asian Phytoceuticals PCL has a GF Score™ of 62/100, reflecting its overall financial health beyond just this single metric.
How does Asian Phytoceuticals PCL's Sloan Ratio % compare to PG and CL?
Asian Phytoceuticals PCL's Sloan Ratio % of -10.39% can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Consumer Packaged Goods company?
A good Sloan Ratio % depends on the Consumer Packaged Goods industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Asian Phytoceuticals PCL and its competitors. Asian Phytoceuticals PCL's current Sloan Ratio % is -10.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asian Phytoceuticals PCL stock overvalued right now?
Asian Phytoceuticals PCL (BKK:APCO-R) has a current Sloan Ratio % of -10.39%. The stock's GF Value™ is ฿7.61, compared to a current price of ฿6.27 — trading 17.6% below its estimated fair value. The current Sloan Ratio % is -10.39%. Asian Phytoceuticals PCL's overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Asian Phytoceuticals PCL (BKK:APCO-R), the current Sloan Ratio % is -10.39% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asian Phytoceuticals PCL (BKK:APCO-R) Overvalued in 2026?
Based on GuruFocus' analysis, Asian Phytoceuticals PCL stock appears to be undervalued.
The current stock price of ฿6.27 is trading 17.6% below its estimated GF Value™ of ฿7.61.
Key valuation signals for BKK:APCO-R:
Sloan Ratio %: -10.39%
GF Value™: ฿7.61 vs. price of ฿6.27 (17.6% below fair value)
No single metric tells the full story. See the BKK:APCO-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asian Phytoceuticals PCL engages in the manufacturing and marketing of herbal healthcare products. The company engages in the production and distribution of dietary supplements, cosmetics, and personal care products made from natural herbs. Its beauty products include skin nourishing and skin care products, hair loss treatment and hair growth products, slimming products, dietary supplements, and other nutritional products. Geographically, the company offers its services only in Thailand.
62GF Score
Get the complete analysis for BKK:APCO-R
Sloan Ratio % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:APCO-R has been successfully added to your 
